Clearly, 2020 was dominated by the Covid-19 pandemic, but that shouldn’t overshadow the key changes in therapeutics and clinical practice that took place during the course of the year. In this round-up, drug safety issues, relevant guidance and practice developments, and quality standards are all put under the spotlight, starting with updates to the Drug Safety Update concerning pregnancy prevention in women taking valproate in February...